Alnylam Pharmaceuticals, Inc.

J.P. Marvel Investment Advisors, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

7,105

Value ($000)

2,825

Weight

0.4%

2013 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	2,825	0.4%	7,105	12/31/2025
2025 Q3	11/12/2025	3,240	0.5%	7,105	9/30/2025
2025 Q2	8/14/2025	2,225	0.4%	6,824	6/30/2025
2014 Q1	5/22/2014	3,562	1.3%	53,055	3/31/2014
2013 Q4	5/22/2014	3,482	1.2%	54,155	12/31/2013